Fibroblasts from non-healing human chronic wounds show decreased expression of βig-h3, a TGF-β inducible protein

Journal of Dermatological Science

Volumn 50, Issue 1, 2008, Pages 15-23

  Cha, Jisun ^a   Kwak, Taehee ^a,b   Butmarc, Janet ^a   Kim, Tae Aug ^b   Yufit, Tatyana ^a   Carson, Polly ^a   Kim, Seong Jin ^b   Falanga, Vincent ^a,c,d  

^a ROGER WILLIAMS MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY   (United States)

Author keywords

ig h3; Chronic wounds; Fibroblasts; TGF ; Wound healing

Indexed keywords

PROTEIN BETA IG H3; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CHRONIC WOUND; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEG ULCER; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN INJURY; THIGH; ULCER; ULCER HEALING; WOUND HEALING;

CHRONIC DISEASE; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; WOUNDS AND INJURIES;

EID: 39149125136     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2007.10.010     Document Type: Article

References (30)

1. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 366 9498 (2005) 1736-1743
2. Kim B.-C., Kim H.T., Park S.H., Cha J.-S., Yufit T., Kim S.-J., et al. Fibroblasts from chronic wounds show altered TGF-beta-signaling and decreased TGF-beta type II receptor expression. J Cell Physiol 195 3 (2003) 331-336
3. Cook H., Stephens P., Davies K.J., Harding K.G., and Thomas DW. Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, and MMP-2 activity. J Invest Dermatol 115 2 (2000) 225-233
4. Agren M.S., Steenfos H.H., Dabelsteen S., Hansen J.B., and Dabelsteen. Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated from chronic venous leg ulcers is ulcer-age dependent. J Invest Dermatol 112 4 (1999) 463-469
5. Hasan A., Murata H., Falabella A., Ochoa S., Zhou L., Badiavas E., et al. Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-beta 1. J Dermatol Sci 16 1 (1997) 59-66
6. Pardes J.B., Takagi H., Martin T.A., Ochoa M.S., and Falanga V. Decreased levels of alpha 1(I) procollagen mRNA in dermal fibroblasts grown on fibrin gels and in response to fibrinopeptide B. J Cell Physiol 162 1 (1995) 9-14
7. Kim Y.J., Kwak C.I., Gu Y.Y., Hwang I.T., and Chun J.Y. Annealing control primer system for identification of differentially expressed genes on agarose gels. Biotechniques 36 3 (2004) 424-426 428, 430 passim
8. Butmarc J., Yufit T., Carson P., and Falanga V. Human beta-defensin-2 expression is increased in chronic wounds. Wound Repair Regen 12 4 (2004) 439-443
9. Falanga V., Schrayer D., Cha J., Butmarc J., Carson P., Roberts A.B., et al. Full-thickness wounding of the mouse tail as a model for delayed wound healing: accelerated wound closure in Smad3 knock-out mice. Wound Repair Regen 12 3 (2004) 320-326
10. Alstadt S.P., Hebda P.A., Chung A.E., and Eaglstein W.H. Effect of basement membrane entactin on epidermal cell attachment and growth. J Invest Dermatol 88 1 (1987) 55-59
11. Hwang I.T., Kim Y.J., Kim S.H., Kwak C.I., Gu Y.Y., and Chun J.Y. Annealing control primer system for improving specificity of PCR amplification. Biotechniques 35 6 (2003) 1180-1184
12. Hwang K.C., Cui X.S., Park S.P., Shin M.R., Park S.Y., Kim E.Y., et al. Identification of differentially regulated genes in bovine blastocysts using an annealing control primer system. Mol Reprod Dev 69 1 (2004) 43-51
13. Liang P. Methods in molecular biology. In: Meade J.D., Liang P., and Pardee A.B. (Eds). Differential display methods and protocols. 2nd ed. (2005), Humana Press Inc., Totowa
14. Gibson M.A., Kumaratilake J.S., and Cleary E.G. The protein components of the 12-nanometer microfibrils of elastic and nonelastic tissues. J Biol Chem 264 8 (1989) 4590-4598
15. Skonier J., Bennett K., Rothwell V., Kosowski S., Plowman G., Wallace P., et al. Beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol 13 6 (1994) 571-584
16. Skonier J., Neubauer M., Madisen L., Bennett K., Plowman G.D., and Purchio A.F. cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol 11 7 (1992) 511-522
17. Hashimoto K., Noshiro M., Ohno S., Kawamoto T., Satakeda H., Akagawa Y., et al. Characterization of a cartilage-derived 66-kDa protein (RGD-CAP/beta ig-h3) that binds to collagen. Biochim Biophys Acta 1355 3 (1997) 303-314
18. Gibson M.A., Kumaratilake J.S., and Cleary E.G. Immunohistochemical and ultrastructural localization of MP78/70 (betaig-h3) in extracellular matrix of developing and mature bovine tissues. J Histochem Cytochem 45 12 (1997) 1683-1696
19. Billings P.C., Herrick D.J., Howard P.S., Kucich U., Engelsberg B.N., and Rosenbloom J. Expression of betaig-h3 by human bronchial smooth muscle cells: localization to the extracellular matrix and nucleus. Am J Respir Cell Mol Biol 22 3 (2000) 352-359
20. LeBaron R.G., Bezverkov K.I., Zimber M.P., Pavelec R., Skonier J., and Purchio A.F. Betaig-h3, a novel secretory protein inducible by transforming growth factor-beta, is present in normal skin and promotes the adhesion and spreading of dermal fibroblasts in vitro. J Invest Dermatol 104 5 (1995) 844-849
21. Rawe I.M., Zhan Q., Burrows R., Bennett K., and Cintron C. Beta-ig: molecular cloning and in situ hybridization in corneal tissues. Invest Ophthalmol Vis Sci 38 5 (1997) 893-900
22. Klintworth G.K., Valnickova Z., and Enghild J.J. Accumulation of betaig-h3 gene product in corneas with granular dystrophy. Am J Pathol 152 3 (1998) 743-748
23. Munier F.L., Korvatska E., Djemai A., Le Paslier D., Zografos L., Pescia G., et al. Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat Genet 15 3 (1997) 247-251
24. Lai C.F., Feng X., Nishimura R., Teitelbaum S.L., Avioli L.V., Ross F.P., et al. Transforming growth factor-beta up-regulates the beta 5 integrin subunit expression via Sp1 and Smad signaling. J Biol Chem 275 46 (2000) 36400-36406
25. Nesti L.J., Caterson E.J., Wang M., Chang R., Chapovsky F., Hoek J.B., et al. TGF-beta1-stimulated osteoblasts require intracellular calcium signaling for enhanced alpha5 integrin expression. Ann NY Acad Sci 961 (2002) 178-182
26. Bartolomé R.A., Sanz-Rodríguez F., Robledo M.M., Hidalgo A., and Teixidó J. Rapid up-regulation of alpha4 integrin-mediated leukocyte adhesion by transforming growth factor-beta1. Mol Biol Cell 14 1 (2003) 54-66
27. Kim J.E., Jeong H.W., Nam J.O., Lee B.H., Choi J.Y., Park R.W., et al. Identification of motifs in the fasciclin domains of the transforming growth factor-beta-induced matrix protein betaig-h3 that interact with the alphavbeta5 integrin. J Biol Chem 277 48 (2002) 46159-46165
28. Jeong H.W., and Kim I.S. TGF-beta1 enhances betaig-h3-mediated keratinocyte cell migration through the alpha3beta1 integrin and PI3K. J Cell Biochem 92 4 (2004) 770-780
29. Nam J.O., Kim J.E., Jeong H.W., Lee S.J., Lee B.H., Choi J.Y., et al. Identification of the alphavbeta3 integrin-interacting motif of betaig-h3 and its anti-angiogenic effect. J Biol Chem 278 28 (2003) 25902-25909
30. Ashcroft G.S., Yang X., Glick A.B., Weinstein M., Letterio J.L., Mizel D.E., et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1 5 (1999) 260-266